HOME >> BIOLOGY >> NEWS
ESC Congress 2005 to utilise studies, sessions and sunshine to shed light on women and CVD

Sophia Antipolis, France, 21 June 2005: With the aim of better understanding and addressing women and cardiovascular disease (CVD), the European Society of Cardiology (ESC) has made women and CVD the focus of its next major annual event, the ESC Congress, which will take place in Stockholm, 3 7 September 2005.

The ESC Congress will highlight women and CVD by revealing results from the ESC Policy Conference and the ESC Euro Heart Survey during specific sessions at the Congress. The ESC also will provide information with regard to women and CVD during a two-day outdoor public event that will run alongside the ESC Congress, entitled 'For Your Heart's Sake,' 2 3 September 2005 in central Stockholm.

In preparation for the ESC Congress' focus, the ESC is convening a Policy Conference on 'CVD in Women' on 23 24 June 2005, which will bring together approximately 60 cardiologists and experts from the 49 ESC member countries to review and discuss medical literature on CVD in women. The group will evaluate the gap between scientific data and the perception about the role of CVD risk factors in women's health. Strategies will be discussed to promote research in the field of CVD in women and to educate both cardiologists and their patients. The results of this conference will be released during the ESC Congress 2005, and also through an article to be published in the European Heart Journal, an official journal of the ESC.

The ESC Congress' selection of sessions on women and CVD will include release of the Euro Heart Survey database analyses with incidence and treatment trends of women with CVD across Europe. Analyses of the Euro Heart Survey databases are expected to greatly contribute to an increased understanding and treatment of women and CVD through insight into manifestation, treatment and co-morbidity patterns in women compared to men.

There will also be a special focus on women and CVD, including specific information on risk factor reduc
'"/>

Contact: Gina Dellios
gdellios@escardio.org
33-492-948-627
European Society of Cardiology
21-Jun-2005


Page: 1 2 3

Related biology news :

1. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
2. 2nd International EuroFIR Congress
3. Prize winners announced at ISNs World Congress of Nephrology
4. Nanotechnologys past, present and future: A Congressional perspective
5. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
6. Minister Lunn to speak at 10th National Forest Congress
7. Conservationist and actor Harrison Ford honored by Congressional Foundation
8. Q&A with Jeffrey Sachs on July 10 at Soils Congress
9. 18th World Congress of Soil Science
10. PITTs McGowan Institute for Regenerative Medicine presenting new research at World Congress
11. International Society of Nephrologys World Congress of Nephrology 2007

Post Your Comments:
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2
(Date:3/3/2015)... , March 3, 2015 NASA astronaut Scott ... this month to spend a year living and working on ... interviews from 5:30 to 7 a.m. EDT Monday, March 9. ... as he completes the final weeks of his training. ... video on NASA Television highlighting his mission training and previous ...
(Date:3/3/2015)... 03, 2015 Research and Markets ( ... "Gene Therapy Market, 2015 - 2025" report to ... 2015-2025" report provides an extensive study on the marketed ... been carried out in this field for over a ... available in Asian markets; one approved in the EU). ...
(Date:3/3/2015)... -- Adaptive Biotechnologies announced today that Chad Cohen ... Director as Chair of the Audit Committee. ... all finance, treasury and accounting functions. Since joining Zillow ... and accounting functions, and led the finance organization through ... was named Puget Sound Business Journal,s CFO of the ...
(Date:3/3/2015)... LITTLE FALLS, N.J. , March 3, 2015 /PRNewswire/ ... a biotechnology company specializing in the development of and ... of damaged tissues and organs, announced today that it ... Purchase Agreement with Amarantus Bioscience Holdings, Inc. (OTC Bulletin ... required under the Agreement, Amarantus made the final payments ...
Breaking Biology Technology:NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3
Cached News: